Innovation is in GenSci's DNA. GenSci advances a robust, innovative portfolio across four therapeutic areas: endocrinology & metabolism, women's health, immunology & respiratory diseases, and oncology.
Guided by global R&D strategy, besides robust research engines, we execute Multi-Regional Clinical Trials (MRCT) with high efficiency and high standards in China and overseas. Our innovation engine is powered by cutting-edge technology platforms, enhanced by AI to enable precision-targeting therapeutic development.
Concurrently, we are building a global R&D network to foster worldwide collaboration. This network is crucial for accelerating our research and development of innovative medicines and ensures our research outcomes finely calibrated to address the complex and diverse needs of global markets.
-
35+
Clinical Pipeline
-
8
Multi-Regional Clinical Trials
-
22%
R&D investment as a percentage of sales revenue in 2024
-
90+
Held Patents；
Pending Applications: 279；
International Patents Submitted: 56
R&D Highlight
We leverage cutting-edge technologies to accelerate drug discovery and build differentiated pipelines targeting major diseases.
-
AI-EmpoweredLeverage AI to speed drug discovery and development
AI-EmpoweredLeverage AI to speed drug discovery and development
-
Top TechnologyDevelop differentiated and leading platforms
Top TechnologyDevelop differentiated and leading platforms
-
Unmet NeedsFocus on therapeutic areas with clinical unmet needs
Unmet NeedsFocus on therapeutic areas with clinical unmet needs
-
Large InvestmentInvest significantly in R&D
Large InvestmentInvest significantly in R&D
-
Global CooperationTeam up with innovators worldwide
Global CooperationTeam up with innovators worldwide
R&D Centers
Five major R&D centers power unceasing innovation
-
Shanghai R&D Center
-
Changchun R&D Center
-
Beijing R&D Center
-
U.S. R&D Center
-
European R&D Center
-
Shanghai R&D CenterEquipped to house 2,000 R&D professionals, this state-of-the-art facility leads in translational medicine and clinical research. It is at the forefront of discovering new drug targets and forging strategic alliances to convert innovative ideas into practical medical solutions.
-
Changchun R&D CenterServes as a vibrant hub of innovation and a nucleus for the industrialization of biopharmaceuticals and chemical medicines, deftly guiding the product development lifecycle from inception to successful market entry.
-
Beijing R&D CenterActively conducts essential medical research and rigorously oversees the new product registration process to meet exacting regulatory standards, critical for our strategic market expansion and product diversification within China.
-
U.S. R&D CenterLocated in Washington D.C., the center is positioned as a strategic nexus for market expansion and R&D tailored to the U.S. market. This center is crucial for aligning our R&D endeavors with the needs of a major pharmaceutical market, thereby enhancing our global competitiveness.
-
European R&D CenterLocated in Lausanne, Switzerland, this center is pivotal to our strategic expansion across Europe, crafting R&D strategies that are in perfect harmony with European regulatory standards. It plays an essential role in keeping our products at the cutting edge of competitiveness and compliance within the European pharmaceutical market.
